Ranitidine
Product Images NDC 71610-378

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 71610-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (6e003da0 3836 4bf7 A7b7 2d72c35b44ee 01)

Structure (6e003da0 3836 4bf7 A7b7 2d72c35b44ee 01)
Chemical structure of ranitidine hydrochloride displaying its molecular arrangement with distinct functional groups including methylamino, furan ring, thioether, and nitroacetamide linked to a hydrochloride group.*
FDA Label Image

Bottle Label 150 mg (71610 0378 30)

Bottle Label 150 mg (71610 0378 30)
Label for Ranitidine Immediate Release 150 mg tablets, package of 30, from Aphena Pharma Solutions - Tennessee, LLC. The label includes storage instructions, drug safety warnings, manufacturer information (Strides Pharma Global Pte. Ltd), and batch details. It indicates the product is for prescription use only (RX Only).*
FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.